Cargando…

Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019

PURPOSE: To report contemporary epidemiological data and treatment trends for upper tract urothelial carcinoma (UTUC) in Germany over a 14-year period. METHODS: We analyzed data from the nationwide German hospital billing database and the German cancer registry from 2006 to 2018/2019. The significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Herout, Roman, Baunacke, Martin, Flegar, Luka, Borkowetz, Angelika, Reicherz, Alina, Koch, Rainer, Kraywinkel, Klaus, Thomas, Christian, Groeben, Christer, Huber, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849285/
https://www.ncbi.nlm.nih.gov/pubmed/36445373
http://dx.doi.org/10.1007/s00345-022-04219-5
_version_ 1784871919546269696
author Herout, Roman
Baunacke, Martin
Flegar, Luka
Borkowetz, Angelika
Reicherz, Alina
Koch, Rainer
Kraywinkel, Klaus
Thomas, Christian
Groeben, Christer
Huber, Johannes
author_facet Herout, Roman
Baunacke, Martin
Flegar, Luka
Borkowetz, Angelika
Reicherz, Alina
Koch, Rainer
Kraywinkel, Klaus
Thomas, Christian
Groeben, Christer
Huber, Johannes
author_sort Herout, Roman
collection PubMed
description PURPOSE: To report contemporary epidemiological data and treatment trends for upper tract urothelial carcinoma (UTUC) in Germany over a 14-year period. METHODS: We analyzed data from the nationwide German hospital billing database and the German cancer registry from 2006 to 2018/2019. The significance of changes over time was evaluated via regression analysis. Survival outcomes were calculated using the Kaplan–Meier method. RESULTS: There was a non-significant increase in the age-standardized incidence rate from 2.5/100,000 in 2006 to 2.9/100.000 in 2018. 13% of patients presented with lymph node metastasis and 7.6% of patients presented with distant metastasis at primary diagnosis. The 5-year overall survival was estimated at 45% and the 10-year overall survival at 32%. Endoscopic biopsies of the renal pelvis and ureter as well as ureteroscopies with excision/destruction of UTUC all increased significantly over the study period. The number of radical nephroureterectomies (RNU) for UTUC steadily increased from 1643 cases in 2006 to 2238 cases in 2019 (p < 0.005) with a shift from open surgery towards minimally invasive surgery. Complex reconstructive procedures like ileal ureter replacement or autotransplantation are rarely performed for urothelial carcinoma of the ureter. CONCLUSION: Diagnostic and therapeutic procedures for UTUC have increased and minimally invasive nephroureterectomy is the predominant approach concerning radical surgery in 2019. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-022-04219-5.
format Online
Article
Text
id pubmed-9849285
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98492852023-01-20 Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019 Herout, Roman Baunacke, Martin Flegar, Luka Borkowetz, Angelika Reicherz, Alina Koch, Rainer Kraywinkel, Klaus Thomas, Christian Groeben, Christer Huber, Johannes World J Urol Original Article PURPOSE: To report contemporary epidemiological data and treatment trends for upper tract urothelial carcinoma (UTUC) in Germany over a 14-year period. METHODS: We analyzed data from the nationwide German hospital billing database and the German cancer registry from 2006 to 2018/2019. The significance of changes over time was evaluated via regression analysis. Survival outcomes were calculated using the Kaplan–Meier method. RESULTS: There was a non-significant increase in the age-standardized incidence rate from 2.5/100,000 in 2006 to 2.9/100.000 in 2018. 13% of patients presented with lymph node metastasis and 7.6% of patients presented with distant metastasis at primary diagnosis. The 5-year overall survival was estimated at 45% and the 10-year overall survival at 32%. Endoscopic biopsies of the renal pelvis and ureter as well as ureteroscopies with excision/destruction of UTUC all increased significantly over the study period. The number of radical nephroureterectomies (RNU) for UTUC steadily increased from 1643 cases in 2006 to 2238 cases in 2019 (p < 0.005) with a shift from open surgery towards minimally invasive surgery. Complex reconstructive procedures like ileal ureter replacement or autotransplantation are rarely performed for urothelial carcinoma of the ureter. CONCLUSION: Diagnostic and therapeutic procedures for UTUC have increased and minimally invasive nephroureterectomy is the predominant approach concerning radical surgery in 2019. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-022-04219-5. Springer Berlin Heidelberg 2022-11-29 2023 /pmc/articles/PMC9849285/ /pubmed/36445373 http://dx.doi.org/10.1007/s00345-022-04219-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Herout, Roman
Baunacke, Martin
Flegar, Luka
Borkowetz, Angelika
Reicherz, Alina
Koch, Rainer
Kraywinkel, Klaus
Thomas, Christian
Groeben, Christer
Huber, Johannes
Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
title Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
title_full Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
title_fullStr Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
title_full_unstemmed Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
title_short Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
title_sort upper tract urothelial carcinoma in germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849285/
https://www.ncbi.nlm.nih.gov/pubmed/36445373
http://dx.doi.org/10.1007/s00345-022-04219-5
work_keys_str_mv AT heroutroman uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT baunackemartin uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT flegarluka uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT borkowetzangelika uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT reicherzalina uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT kochrainer uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT kraywinkelklaus uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT thomaschristian uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT groebenchrister uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019
AT huberjohannes uppertracturothelialcarcinomaingermanyepidemiologicaldataandsurgicaltreatmenttrendsinatotalpopulationanalysisfrom2006to2019